[Arterial pO2 modified by Complamin in hyaline membrane disease and aspiration syndromes of premature and term infants].
D002404:Catheterization; D005260:Female; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy / Q000503:physiopathology*; D000860:Hypoxia / Q000188:drug therapy*; D007231:Infant, Newborn; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D011015:Pneumonia, Aspiration / Q000188:drug therapy / Q000503:physiopathology*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000503:physiopathology*; D013806:Theophylline / Q000627:therapeutic use*; D014471:Umbilical Veins
D009539:Nicotinic Acids; D013806:Theophylline; D010100:Oxygen
Der Effekt von Complamin auf den arteriellen pO2 beim Membransyndrom und beim Aspirationssyndrom der Früh- und Neugeborenen.